Last €10.00 EUR
Change Today +0.007 / 0.07%
Volume 0.0
BSND On Other Exchanges
EN Paris
SIX Swiss Ex
As of 10:53 AM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

danone-spons adr (BSND) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/28/13 - €11.69
52 Week Low
03/19/14 - €9.60
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for DANONE-SPONS ADR (BSND)

Related News

No related news articles were found.

danone-spons adr (BSND) Details

Danone produces and distributes food and beverage products. The company’s Fresh Dairy Products division provides yogurts, fermented fresh dairy products, and specialized dairy products under the Activia, Danonino, Fruchtswerge, Danoninho, Petit Gervais, Danimals, Serenito, Milkuat, Tëma, Actimel, Danacol, Densia, Oikos, Danio, Danette, Fantasia, Danissimo, YoCrunch, Vitalinea, Taillefine, and Ser brands. Its Waters division offers packaged natural, flavored, and vitamin-enriched water under Evian, Volvic, Bonafont, Mizone, Aqua, Fontvella, Lanjarón, Villavicencio, Villa del Sur, and Zywiec Zdroj brands. The company’s Early Life Nutrition division produces and distributes specialized food for babies and young children to complement breast-feeding, as well as solid foods for babies under Aptamil, Nutrilon, Almiron, Gallia, Bebelac, Cow&Gate, Blédina, and Malyutka brands. Its Medical Nutrition division provides specialized food for people receiving medical treatment, babies afflicted with certain illnesses, and frail elderly people. Its products include liquid oral nutritional supplements; hypoallergenic products; oral and feeding tube food products for the dietary treatment of infants and children who are incapable of feeding themselves or suffer from illness related malnutrition; and nutritional products for special medical needs. This division markets its products primarily under the Nutricia brand. The company serves individual consumers, retail chains, and traditional market outlets, as well as specialized distribution channels of hospitals, clinics, and pharmacies. It has operations in Russia, France, the United States, China, Indonesia, Spain, Mexico, Argentina, the United Kingdom, and Brazil. Danone has a strategic agreement with Starbucks to create and develop a line of Dannon-branded fresh dairy products. The company was formerly known as Groupe Danone and changed its name to Danone in April 2009. Danone was founded in 1899 and is based in Paris, France.

104,642 Employees
Last Reported Date: 03/24/14
Founded in 1899

danone-spons adr (BSND) Top Compensated Officers

Vice Chairman, Chief Executive Officer and Me...
Total Annual Compensation: €1.4M
Compensation as of Fiscal Year 2013.

danone-spons adr (BSND) Key Developments

Fresenius, PE Firms Reportedly Eye Danone's Medical Nutrition Unit

Fresenius SE & Co KGaA (DB:FRE) and private equity houses PAI Partners and Permira Advisers Ltd. are reportedly weighing bids for the medical nutrition unit of Danone (ENXTPA:BN), sources familiar with the situation told Reuters. Fresenius sought to take over the division earlier in 2014 but withdraw from the deal as it considered the price asked to be too high, sources told Reuters. Any agreement is still months away as the transaction is considered a complex one, the news agency noted. PAI is ready to strike any deal for the division along with co-investors, one of the sources added. All companies mentioned declined to comment when contacted by Reuters.

Danone Reportedly Seeks To Acquire Mead Johnson

Danone (ENXTPA:BN) has decided it wants to pursue a takeover of Mead Johnson Nutrition Company (NYSE:MJN), sources familiar with the matter told Reuters. "Danone has done its internal strategic review and decided that Mead Johnson is its preferred acquisition," one of the sources said, speaking on condition of anonymity because the matter is private.

Danone Reports Group Sales Results for the Third Quarter and Nine Months of 2014; Provides Earnings Guidance for the Second Half and Full Year of 2014

Danone reported group sales results for the third quarter and nine months of 2014. For the quarter, the group's sales were EUR 5,416 million against EUR 5,259 million a year ago. For the nine months, the group's sales were EUR 15,883 million against EUR 16,317 million a year ago. Due to the rebuilding effort and to 2013 bases for comparison, organic growth in sales and operating margin will vary widely from one half to the next in 2014. The group thus anticipates a return to strong, sustainable, profitable growth beginning in the second half. Danone has set the following targets for full-year 2014: like-for-like sales growth of between 4.5% and 5.5%, trading operating margin stable within a range of -20 bps and +20 bps, reflecting the flexibility that the group seeks to manage its operations, in particular for its Early Life Nutrition business in Asia, and free cash-flow of around 1.5 billion excluding exceptional items.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BSND:GR €10.00 EUR +0.007

BSND Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Associated British Foods PLC 2,693 GBp +58.00
Baxter International Inc $68.25 USD +0.3135
Fresenius SE & Co KGaA €37.75 EUR -0.07
Kraft Foods Group Inc $56.39 USD +0.51
Mondelez International Inc $33.06 USD +0.12
View Industry Companies

Industry Analysis


Industry Average

Valuation BSND Industry Range
Price/Earnings 26.0x
Price/Sales 1.3x
Price/Book 2.5x
Price/Cash Flow 28.5x
TEV/Sales 0.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DANONE-SPONS ADR, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at